Yu, Y., & Hinderling, P. H. (2024). Can non-renal clearance and/or bioavailability of drugs be assessed reliably in renal impairment studies with oral drug administration? International journal of clinical pharmacology and therapeutics, 62(3), 129-141. https://doi.org/10.5414/CP204451
Chicago Style (17th ed.) CitationYu, Yichao, and Peter H. Hinderling. "Can Non-renal Clearance And/or Bioavailability of Drugs Be Assessed Reliably in Renal Impairment Studies with Oral Drug Administration?" International Journal of Clinical Pharmacology and Therapeutics 62, no. 3 (2024): 129-141. https://doi.org/10.5414/CP204451.
MLA (9th ed.) CitationYu, Yichao, and Peter H. Hinderling. "Can Non-renal Clearance And/or Bioavailability of Drugs Be Assessed Reliably in Renal Impairment Studies with Oral Drug Administration?" International Journal of Clinical Pharmacology and Therapeutics, vol. 62, no. 3, 2024, pp. 129-141, https://doi.org/10.5414/CP204451.